UNSPSC 85361601: Diagnosis of rapidly progressive nephritic syndrome, minor glomerular abnormality

This classification denotes the group of activities that yields a diagnosis of Rapidly progressive nephritic syndrome on the minor glomerular abnormality. Rapidly progressive nephritic syndrome on the minor glomerular abnormality is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as a four digit category under code N01. 0

UNSPSC 85361601 (Diagnosis of rapidly progressive nephritic syndrome, minor glomerular abnormality) is a Commodity code that shows a significant mismatch between its nominal clinical scope and recent state and local procurement activity. The three most recent opportunities posted under this code involve diagnostic imaging system implementation, special education contracted services, and temporary health professional staffing — none of which align with the nephritic syndrome diagnosis nomenclature. This code appears to exhibit tagging misalignment at the source, suggesting either a data-entry error in how opportunities are being classified or a broader taxonomy incongruity that limits its utility for procurement tracking.

State and local sources posting under this code in the past quarter include a major health system (San Mateo Medical Center under San Mateo County), a school district (Birdville Independent School District in Texas), and a county health system (Santa Clara County Health System in California). The opportunities themselves span enterprise technology procurement (a diagnostic imaging PACS system RFP with a response date of October 21, 2026), human services contracting (special education staffing with an October 21, 2026 deadline), and healthcare staffing qualification vehicles (Santa Clara's temporary health professional staffing RFQ due October 7, 2026). Given the absence of meaningful alignment between the code's stated definition and the recent solicitations appearing under it, this code does not present a reliable signal for business development targeting of state and local procurement in its purported clinical specialty.